Search on website
Filters
Show more
idea-icon

Summary of the Day

Down Syndrome

Read Summary chevron-left-black
note-icon

Question of the Day

A 18-year-old woman with a family history of pseudocholinesterase deficiency requires an emergent laparotomy after a motor vehicle accident and is given succinylcholine 100 mg IV in the emergency department. After a two-hour surgical procedure, the patient remains paralyzed. She is taken to the ICU for mechanical ventilation for presumed pseudocholinesterase deficiency and remains without motor activity 6 hours postoperatively. Which of the following combinations of pseudocholinesterase deficiency and dibucaine number are MOST likely in this situation?

Question of the Day
A 18-year-old woman with a family history of pseudocholinesterase deficiency requires an emergent laparotomy after a motor vehicle accident and is given succinylcholine 100 mg IV in the emergency department. After a two-hour surgical procedure, the patient remains paralyzed. She is taken to the ICU for mechanical ventilation for presumed pseudocholinesterase deficiency and remains without motor activity 6 hours postoperatively. Which of the following combinations of pseudocholinesterase deficiency and dibucaine number are MOST likely in this situation?
Your Answer
Correct Answer

Explanation

Pseudocholinesterase (or plasma cholinesterase) is produced in the liver and metabolizes succinylcholine, ester local anesthetics, and mivacurium. Inherited forms of pseudocholinesterase deficiency occur as a result of mutations on the long arm of chromosome 3. Dibucaine is an amide local anesthetic that inhibits normal plasma cholinesterase by 80% and the atypical enzyme by 20%. The dibucaine number characterizes the ability to metabolize succinylcholine but does not reflect the quantity of enzyme. Normal homozygote has dibucaine number 80 with normal response to succinylcholine. Atypical heterozygote has dibucaine number 50-60 with prolonged duration of action for succinylcholine of 50-100%. Atypical homozygote has dibucaine number 20 with prolonged neuromuscular blockade with succinylcholine of 4-8 hours.

OA Series: March 2025

vodcast-icon-blue-2 Vodcast

play-icon-2 15:42

OA-POCUS Case of the Month

Introduction to Lung Ultrasound

Yuriy Bronshteyn, MD, FASE, Duke University Health System, Durham, NC

vodcast-icon-blue-2 Vodcast

play-icon-2 03:51

Pediatric Anesthesia Vodcast (en Español)

Consideraciones Perioperatorias: Bronchoespamo en Anestesia Pediátrica

Marco V. Padilla, MD, Tegucigalpa, Honduras